BIOMEA FUSION INC. - COMMON STOCK
6.4400
22-十一月-24 16:44:58
15 分钟延时
股票
+0.0600
+0.94%
今日范围
6.2300 - 6.7399
ISIN
N/A
来源
NASDAQ
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01 11月 2024 16:05:51 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Reports Third Quarter 2024 Financial Results and Corporate Highlights
29 10月 2024 16:46:08 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Announces Approval of “icovamenib” as International Nonproprietary Name for BMF-219
21 10月 2024 09:00:29 条件 Nasdaq GlobeNewswire
-
15 10月 2024 16:05:19 条件 Nasdaq GlobeNewswire
-
07 10月 2024 09:00:41 条件 Nasdaq GlobeNewswire
-
01 10月 2024 09:00:01 条件 Nasdaq GlobeNewswire
-
FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials
26 9月 2024 14:00:57 条件 Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
01 8月 2024 16:05:20 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Reports Second Quarter 2024 Financial Results and Corporate Highlights
31 7月 2024 16:05:22 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Announces BMF-219 in Diabetes Placed on Clinical Hold
06 6月 2024 16:05:53 条件 Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
03 6月 2024 16:05:29 条件 Nasdaq GlobeNewswire
-
30 5月 2024 09:12:39 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Reports First Quarter 2024 Financial Results and Corporate Highlights
02 5月 2024 16:05:01 条件 Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 5月 2024 16:10:28 条件 Nasdaq GlobeNewswire
-
Biomea Fusion, Inc. Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
01 4月 2024 16:10:59 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Highlights Initial Data from the First Two Type 1 Diabetes Patients Dosed with BMF-219
01 4月 2024 09:02:04 条件 Nasdaq GlobeNewswire
-
Biomea Fusion Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights
01 4月 2024 09:00:11 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >